Understand the source comparison
SS-LUP-332 vs Traditional Research Compounds: Cycling Protocol Comparison
Growth Hormone Secretagogues (GHRP-2, Ipamorelin) 2–4 hours Complete within 24 hours 4–6 weeks on, 2–4 weeks off 2–3 weeks Yes. Pulsatile dosing 2–3×/day Healing Peptides (BPC-157, TB-500) 4–6 hours Complete within 48 hours 4–8 weeks continuous 4 weeks minimum
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues (GHRP-2, Ipamorelin)
- 2–4 hours
- Complete within 24 hours
- 4–6 weeks on, 2–4 weeks off
- 2–3 weeks
- Yes. Pulsatile dosing 2–3×/day
- Healing Peptides (BPC-157, TB-500)
- 4–6 hours
- Complete within 48 hours
- 4–8 weeks continuous
- 4 weeks minimum
- Yes. Once or twice daily
- SARMs (Ostarine, LGD-4033)
- 24 hours
- Complete within 5–7 days
- 8–12 weeks on, 4–8 weeks off
- 4–6 weeks
- Yes. Once daily
- SS-LUP-332 (Lupeol-Derived)
- 72+ hours
- Partial after 96 hours, complete after 10–14 days
- Not applicable. Use intermittent dosing
- 3–4 weeks from last dose
- No. Creates sustained receptor saturation
- Professional Assessment
- SS-LUP-332 requires fundamentally different protocol architecture due to lipid raft binding and extended membrane residence time. Traditional cycling produces inconsistent results and premature receptor desensitisation.